HEADER HYDROLASE/HYDROLASE INHIBITOR 29-OCT-17 5YOK TITLE STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR KNI-1657 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.ADACHI,K.HIDAKA,R.KUROKI,Y.KISO REVDAT 2 27-MAR-24 5YOK 1 COMPND HETNAM REVDAT 1 18-JUL-18 5YOK 0 JRNL AUTH K.HIDAKA,T.KIMURA,R.SANKARANARAYANAN,J.WANG,K.F.MCDANIEL, JRNL AUTH 2 D.J.KEMPF,M.KAMEOKA,M.ADACHI,R.KUROKI,J.T.NGUYEN,Y.HAYASHI, JRNL AUTH 3 Y.KISO JRNL TITL IDENTIFICATION OF HIGHLY POTENT HUMAN IMMUNODEFICIENCY VIRUS JRNL TITL 2 TYPE-1 PROTEASE INHIBITORS AGAINST LOPINAVIR AND DARUNAVIR JRNL TITL 3 RESISTANT VIRUSES FROM ALLOPHENYLNORSTATINE-BASED JRNL TITL 4 PEPTIDOMIMETICS WITH P2 TETRAHYDROFURANYLGLYCINE. JRNL REF J. MED. CHEM. V. 61 5138 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29852069 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01709 REMARK 2 REMARK 2 RESOLUTION. 0.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.103 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.103 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.125 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 10024 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 200529 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.097 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.118 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 9062 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 181768 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 537 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 ANGLE DISTANCES (A) : 2.130 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5YOK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1300005635. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.800 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 200529 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.850 REMARK 200 RESOLUTION RANGE LOW (A) : 34.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 11.10 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 50.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.33100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 126MM PHOSPHATE BUFFER AT PH 5.0, 63MM REMARK 280 SODIUM CITRATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.12500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.97400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.12500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.97400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 393 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 413 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 30 O HOH B 201 1.37 REMARK 500 HE3 LYS B 43 O HOH B 247 1.54 REMARK 500 O HOH A 290 O HOH A 428 1.58 REMARK 500 O HOH B 266 O HOH B 340 1.59 REMARK 500 O HOH B 416 O HOH B 418 1.74 REMARK 500 O ILE A 50 O HOH A 203 1.80 REMARK 500 O HOH B 208 O HOH B 349 1.84 REMARK 500 CG ASP B 30 O HOH B 201 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 237 O HOH B 416 3556 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 57 CZ ARG A 57 NH1 0.115 REMARK 500 GLU A 65 CD GLU A 65 OE2 -0.067 REMARK 500 ILE B 33 CB ILE B 33 CG1 -0.196 REMARK 500 GLU B 65 CB GLU B 65 CG -0.164 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = 6.7 DEGREES REMARK 500 LYS A 45 CD - CE - NZ ANGL. DEV. = 17.2 DEGREES REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 13.5 DEGREES REMARK 500 ILE A 62 O - C - N ANGL. DEV. = -13.5 DEGREES REMARK 500 LEU A 97 CB - CA - C ANGL. DEV. = -13.7 DEGREES REMARK 500 LEU A 97 CB - CA - C ANGL. DEV. = 12.8 DEGREES REMARK 500 GLN B 2 CG - CD - NE2 ANGL. DEV. = 17.2 DEGREES REMARK 500 ASP B 25 CB - CG - OD1 ANGL. DEV. = -8.4 DEGREES REMARK 500 LYS B 43 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 LYS B 45 CB - CG - CD ANGL. DEV. = 17.8 DEGREES REMARK 500 LYS B 45 CG - CD - CE ANGL. DEV. = 23.8 DEGREES REMARK 500 MET B 46 CG - SD - CE ANGL. DEV. = -10.4 DEGREES REMARK 500 GLY B 49 C - N - CA ANGL. DEV. = 17.4 DEGREES REMARK 500 GLU B 65 OE1 - CD - OE2 ANGL. DEV. = 7.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 35 125.98 -38.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ILE A 62 -15.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 491 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 492 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A 493 DISTANCE = 6.08 ANGSTROMS REMARK 525 HOH A 494 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH A 495 DISTANCE = 6.56 ANGSTROMS REMARK 525 HOH A 496 DISTANCE = 6.64 ANGSTROMS REMARK 525 HOH A 497 DISTANCE = 6.82 ANGSTROMS REMARK 525 HOH A 498 DISTANCE = 6.85 ANGSTROMS REMARK 525 HOH A 499 DISTANCE = 7.00 ANGSTROMS REMARK 525 HOH A 500 DISTANCE = 7.16 ANGSTROMS REMARK 525 HOH A 501 DISTANCE = 7.42 ANGSTROMS REMARK 525 HOH A 502 DISTANCE = 7.48 ANGSTROMS REMARK 525 HOH A 503 DISTANCE = 7.66 ANGSTROMS REMARK 525 HOH A 504 DISTANCE = 7.80 ANGSTROMS REMARK 525 HOH A 505 DISTANCE = 8.43 ANGSTROMS REMARK 525 HOH B 425 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH B 426 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH B 427 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH B 428 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH B 429 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH B 430 DISTANCE = 7.30 ANGSTROMS REMARK 525 HOH B 431 DISTANCE = 7.48 ANGSTROMS REMARK 525 HOH B 432 DISTANCE = 9.61 ANGSTROMS REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (4R)-N-[(2,6-DIMETHYLPHENYL)METHYL]-3-[(2S,3S)-3- REMARK 630 [[(2S)-2-[(7-METHOXY-1-BENZOFURAN-2-YL)CARBONYLAMINO]-2-[(3R)- REMARK 630 OXOLAN-3 -YL]ETHANOYL]AMINO]-2-OXIDANYL-4-PHENYL-BUTANOYL]-5,5- REMARK 630 DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 8Z0 A 101 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 8YO 8YR 005 00B 8YU REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8Z0 A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 102 DBREF 5YOK A 0 99 PDB 5YOK 5YOK 0 99 DBREF 5YOK B 0 99 PDB 5YOK 5YOK 0 99 SEQRES 1 A 100 MET PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR SEQRES 2 A 100 ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP SEQRES 3 A 100 THR GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU SEQRES 4 A 100 PRO GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY SEQRES 5 A 100 GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE SEQRES 6 A 100 GLU ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL SEQRES 7 A 100 GLY PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU SEQRES 8 A 100 THR GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 100 MET PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR SEQRES 2 B 100 ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP SEQRES 3 B 100 THR GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU SEQRES 4 B 100 PRO GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY SEQRES 5 B 100 GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE SEQRES 6 B 100 GLU ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL SEQRES 7 B 100 GLY PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU SEQRES 8 B 100 THR GLN ILE GLY ALA THR LEU ASN PHE HET 8Z0 A 101 204 HET GOL B 101 12 HET GOL B 102 6 HETNAM 8Z0 (4R)-N-[(2,6-DIMETHYLPHENYL)METHYL]-3-[(2S,3S)-3- HETNAM 2 8Z0 [[(2S)-2-[(7-METHOXY-1-BENZOFURAN-2-YL)CARBONYLAMINO]- HETNAM 3 8Z0 2-[(3R)-OXOLAN-3 -YL]ETHANOYL]AMINO]-2-OXIDANYL-4- HETNAM 4 8Z0 PHENYL-BUTANOYL]-5,5-DIMETHYL-1,3-THIAZOLIDINE-4- HETNAM 5 8Z0 CARBOXAMIDE HETNAM GOL GLYCEROL HETSYN 8Z0 KNI-1657 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 8Z0 C41 H48 N4 O8 S FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 HOH *537(H2 O) HELIX 1 AA1 GLY A 86 THR A 91 1 6 HELIX 2 AA2 GLY B 86 THR B 91 1 6 SHEET 1 AA1 4 GLN A 2 ILE A 3 0 SHEET 2 AA1 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA1 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 96 SHEET 4 AA1 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AA2 8 TRP A 42 GLY A 49 0 SHEET 2 AA2 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 AA2 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 AA2 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 AA2 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 AA2 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 AA2 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 AA2 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 AA3 8 LYS B 43 GLY B 49 0 SHEET 2 AA3 8 GLY B 52 ILE B 66 -1 O GLY B 52 N GLY B 49 SHEET 3 AA3 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 AA3 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 AA3 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 AA3 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 AA3 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 AA3 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SITE 1 AC1 44 TRP A 6 ARG A 8 LEU A 23 ASP A 25 SITE 2 AC1 44 GLY A 27 ALA A 28 ASP A 29 ASP A 30 SITE 3 AC1 44 GLY A 48 GLY A 49 ILE A 50 PRO A 81 SITE 4 AC1 44 VAL A 82 ILE A 84 HOH A 202 HOH A 207 SITE 5 AC1 44 HOH A 212 HOH A 220 HOH A 247 HOH A 248 SITE 6 AC1 44 HOH A 282 HOH A 288 HOH A 308 HOH A 367 SITE 7 AC1 44 HOH A 442 HOH A 499 ARG B 8 LEU B 23 SITE 8 AC1 44 ASP B 25 GLY B 27 ALA B 28 ASP B 29 SITE 9 AC1 44 ASP B 30 VAL B 32 GLY B 48 GLY B 49 SITE 10 AC1 44 ILE B 50 PRO B 81 VAL B 82 ILE B 84 SITE 11 AC1 44 HOH B 210 HOH B 354 HOH B 399 HOH B 429 SITE 1 AC2 12 GLN A 18 MET A 36 SER A 37 THR B 12 SITE 2 AC2 12 ILE B 13 LYS B 14 LEU B 19 GLU B 65 SITE 3 AC2 12 ALA B 67 GLY B 68 HOH B 232 HOH B 260 SITE 1 AC3 8 HOH A 407 GLU B 35 LYS B 55 ARG B 57 SITE 2 AC3 8 VAL B 77 GLY B 78 HOH B 206 HOH B 278 CRYST1 58.250 85.948 46.529 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017167 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021492 0.00000